Category: Press Release - Page 116 - Psychedelic Alpha

Part 3 of our Year in Review video series is out now.

Read more about the article Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio

Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio

Post published:July 8, 2021
Post category:Press Release

Read more about the article Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone Health for Intellectual Property and Data on Psilocybin and Related Psychedelics for the Treatment of Mental Illness in Patients with Life-Threatening Diseases, Including Cancer

Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone Health for Intellectual Property and Data on Psilocybin and Related Psychedelics for the Treatment of Mental Illness in Patients with Life-Threatening Diseases, Including Cancer

Post published:July 7, 2021
Post category:Press Release

Read more about the article Awakn Establishes Separate Preclinical and Clinical Expert Advisory Boards to Optimize Delivery of Its Expanding Development Pipeline

Awakn Establishes Separate Preclinical and Clinical Expert Advisory Boards to Optimize Delivery of Its Expanding Development Pipeline

Post published:July 7, 2021
Post category:Press Release

Read more about the article Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved Safety in Head-to-Head Comparison to Psilocybin for its First Lead Clinical Candidate, MSP-1014

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved Safety in Head-to-Head Comparison to Psilocybin for its First Lead Clinical Candidate, MSP-1014

Post published:July 7, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations

Post published:July 7, 2021
Post category:Press Release

Read more about the article Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical Trial

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical Trial

Post published:July 7, 2021
Post category:Press Release

Read more about the article MYND Life Sciences Provides Corporate Update

MYND Life Sciences Provides Corporate Update

Post published:July 7, 2021
Post category:Press Release

Read more about the article Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Post published:July 7, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Expands Executive Leadership Team

Delix Therapeutics Expands Executive Leadership Team

Post published:July 6, 2021
Post category:Press Release

Read more about the article Horizons ETFs Rebalances World’s First Psychedelics ETF

Horizons ETFs Rebalances World’s First Psychedelics ETF

Post published:July 6, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.